Form 4: Colgate-Palmolive CFO Exercises, Sells Stock Options
Insider Transaction Report
Colgate-Palmolive's Chief Financial Officer, Stanley J. Sutula III, exercised stock options and subsequently sold 97,843 shares of common stock.
Summary
- Stanley J. Sutula III, Chief Financial Officer of Colgate-Palmolive Co. (CL), engaged in transactions involving the company's common stock.
- On February 4, 2026, Sutula exercised stock options to acquire 97,843 shares of common stock at an exercise price of $81.78 per share.
- Concurrently, Sutula sold 97,843 shares of common stock at a weighted average price of $94.2662 per share, with prices ranging from $93.97 to $94.53.
- A portion of the proceeds from the sale was used to cover the exercise price of the options and related tax withholding obligations.
- Following these transactions, Sutula directly holds 55,310 shares of common stock and indirectly holds 328 shares through the Issuer's 401(k) Plan Trustee.
- The exercised options were granted under the company's incentive compensation plan and became exercisable in one-third increments starting November 9, 2021, with an expiration date of November 9, 2028.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral event. It's a standard executive compensation transaction, not indicative of significant positive or negative operational news for the company.
Positives
- The exercise of stock options indicates that the options were "in the money," meaning the market price was higher than the exercise price, allowing the CFO to realize a gain.
- The transaction is a routine part of executive compensation, demonstrating the executive's participation in the company's incentive plan.
Negatives
- The sale of shares by a key executive, even if for tax and exercise cost coverage, reduces their direct ownership stake in the company.
Industry Context
StockSavvy.ai notes that such transactions are common for executives who receive stock options as part of their compensation packages. The exercise and immediate sale often reflect a strategy to monetize vested options while covering associated taxes and exercise costs, rather than a direct statement on the company's future prospects.
Stakeholder Impact
- Shareholders: The sale slightly reduces the CFO's direct ownership, but the transaction is a routine part of executive compensation and unlikely to have a material impact on shareholder value or perception beyond the immediate reporting.
Key Dates
| Date | Description |
|---|---|
| 2020-11-09 | Grant date of the stock options, which became exercisable in one-third increments starting on the first anniversary. |
| 2026-02-04 | Date of stock option exercise and subsequent sale of common stock. |
| 2026-02-06 | Date the Form 4 was signed by Kristine Hutchinson, Attorney-in-Fact. |
| 2028-11-09 | Expiration date of the stock options. |
Recommendation
holdThe filing details a routine insider transaction where the CFO exercised stock options and sold shares to cover the exercise price and taxes. This is a common practice and does not provide new fundamental information about Colgate-Palmolive's operational performance or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event is neutral in its implications for the stock's intrinsic value.
Keywords
Colgate-Palmolive, CL, Stanley J. Sutula III, CFO, Stock Options, Insider Trading, SEC Form 4, Executive Compensation, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.